Digital Health

Even before COVID-19, disruptive digital health technologies were beginning to revolutionize healthcare. Digital health and telemedicine innovations like telehealth portals, wearables that track biometric data, and devices with Bluetooth connectivity that allow for remote monitoring continue to help increase access to healthcare. New technologies enabling more precise diagnostics and better targeted therapies, and technologies enhancing the efficacy or safety of existing therapies are also expanding. Mobile clinics and portable devices are taking healthcare to people where they live and work. New federal regulations promoting access to data through the use of APIs are fueling the development of new, interoperable technology solutions to further personalize healthcare.

King & Spalding’s Digital Health Group has guided the technology companies, pharmaceutical and device companies, diagnostic companies, start-ups, and healthcare providers that have pioneered the technology and transformative thinking that shape today’s evolving digital health landscape. Our team -- which includes former FDA and other government insiders, as well as thought leaders in privacy and cybersecurity, health and technology -- offers an unparalleled breadth of experience and perspective. The firm helps clients navigate FDA’s regulatory framework pre- and post-market, secure government reimbursement, and advocate in Congress for legislation. Our lawyers also help companies, from start-ups to global brands, in investigations, TCPA class actions, capital raising, M&A, strategic collaborations, antitrust, and intellectual property– all in pursuit of practical solutions that minimize legal risk.